Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance

Lung cancer is the leading cause of cancer deaths in the world. At present, immunotherapy has made a great breakthrough in lung cancer treatment. A variety of immune checkpoint inhibitors have been applied into clinical practice, including antibodies targeting the programmed cell death-1, programmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Fanming, Wang, Ziwei, Liao, Dongying, Zuo, Jinhui, Xie, Hongxia, Li, Xiaojiang, Jia, Yingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438235/
https://www.ncbi.nlm.nih.gov/pubmed/34532293
http://dx.doi.org/10.3389/fonc.2021.739191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438235/
https://www.ncbi.nlm.nih.gov/pubmed/34532293
http://dx.doi.org/10.3389/fonc.2021.739191

Ejemplares similares